Video Library

AUA/SUO Guideline Effects
Gary Steinberg, MD

Dr. Steinberg describes the work that was involved in creating the 2016 AUA/SUO Non-Muscle Invasive Bladder Cancer Guideline. He points out several additions and updates that make the guideline more useful in clinical practice. He also discusses some of the specifics around Blue Light Cystoscopy with Cysview in the guideline and in his practice.

AUA/SUO Guideline Treatment Algorithm
Gary Steinberg, MD

Dr. Steinberg discusses how the AUA/SUO guideline for non-muscle invasive bladder cancer includes a treatment algorithm that outlines steps that urologists can take prior to and following a TURBT to better predict and manage disease progression.

 

AUA/SUO Guideline Effects
Michael O’Donnell, MD

Dr. O’Donnell explains how the AUA/SUO Guideline is written with the patient in mind. He also discusses how to use the guideline in non-muscle invasive bladder cancer patient care.

Enhanced Cystoscopy Benefits the Patient
Sima Porten, MD

Dr. Porten discusses the AUA/SUO guideline for non-muscle invasive bladder cancer and the benefits for patients. She also explains the importance of training residents on how to do a complete resection.

Efficacy and Safety of
Flexible BLC with Cysview

Michael O’Donnell, MD

The approval of Blue Light Cystoscopy with Cysview in the office setting creates improved opportunity for patient care. In this short video, Dr. O’Donnell discusses the advantages and what patients should ask their urologists. He also shares the impact on his practice, including non-muscle invasive bladder cancer patient types for surveillance using Blue Light Cystoscopy with Cysview.

Efficacy and Safety of
Flexible BLC with Cysview

Sia Daneshmand, MD

Dr. Daneshmand explains the objectives of the Cysview Flexible Cystoscopy Clinical Study and reports on how they were met. He describes, in detail, how the study was conducted and the resulting data. He also discusses the study results and implications for clinical use with non-muscle invasive bladder cancer patients.

Efficacy and Safety of
Flexible BLC with Cysview Pt 1

Badrinath Konety, MD

Dr. Konety describes the Blue Light Cystoscopy with Cysview Prospective Registry Study and its objectives. In addition, he discusses what patients think about Blue Light Cystoscopy with Cysview.

Efficacy and Safety of
Flexible BLC with Cysview Pt 2

Badrinath Konety, MD

Dr. Konety defines the primary and secondary objectives of the Cysview Flexible Cystoscopy Clinical Study and presents the endpoint data. He also discusses the findings related to repetitive use and safety of Blue Light Cystoscopy with Cysview. In addition, he describes the potential impact of having flexible Blue Light Cystoscopy with Cysview available in the office setting.

Efficacy and Safety of
Flexible BLC with Cysview

Gary Steinberg, MD

Dr. Steinberg explains the Cysview Flexible Cystoscopy Clinical Study and discusses the resulting data and implications for patient care. He describes the impact of Blue Light Cystoscopy with Cysview related to detection of carcinoma in situ (CIS) and also discusses use of BCG alone in the treatment of CIS. Dr. Steinberg presents the impact of Blue Light Cystoscopy with Cysview on the management of non-muscle invasive bladder cancer patients in the office setting and shares how he uses Blue Light Cystoscopy with Cysview in his practice. He also explains the study data related to false negatives and false positives.

The Role of Repeat TURBT
Gary Steinberg, MD

A TURBT is a visual operation. Dr. Steinberg relates how using white light and blue light with Cysview is almost like the difference between watching TV in black-and-white versus in color and high definition. He also defines use of repeat TURBT.

False Positive Rates with WLC and
BLC with Cysview

Yair Lotan, MD

Before the introduction of enhanced cystoscopy, the realities about white light false positives were not really considered. Dr. Lotan discusses false-positive rates with both White Light and Blue Light Cystoscopies. He also explains Patient-Reported Outcomes related to a Cysview clinical trial.

How I Use BLC with Cysview and Why
Yair Lotan, MD

Dr. Lotan discusses how he uses Blue Light Cystoscopy with Cysview in his practice for his intermediate and high-risk patients. He also explains how urologists might incorporate guidelines that recommend Blue Light Cystoscopy with Cysview and describes how that practice might benefit non-muscle invasive bladder cancer patients.

Cytology
Yair Lotan, MD

Historically, cytology was regarded as being highly sensitive for high-grade disease and was used as a back-up to White Light Cystoscopy. In this short video, Dr. Lotan explains how enhanced cystoscopy finds carcinoma that is not indicated by cytology and the resulting impact on use of cytology.

Trends in Bladder Cancer Management
Ashish Kamat, MD

This is a great time for the field of bladder cancer. Dr. Kamat discusses several developments and their impact on patient care. He also describes the importance of using Blue Light Cystoscopy with Cysview to improve the completeness of TURBTs. In addition, he addresses the topic of BCG-unresponsive disease.

BCG and the Role of BLC with Cysview
Ashish Kamat, MD

Dr. Kamat defines the patient types appropriate for BCG treatment and how they might also be appropriate for Blue Light Cystoscopy with Cysview. He describes the best way to incorporate Blue Light Cystoscopy with Cysview in these patients and the critical impact it might have. He also discusses use in both the OR and office settings to deliver personalized patient care.

Challenges and Treatment of
Unresponsive Disease

Ashish Kamat, MD

It is a big clinical challenge when bladder cancer is unresponsive to BCG treatment. Dr. Kamat presents a short overview on how an incomplete TURBT could be what’s making BCG ineffective.

New Technologies and Effects on TURBT
Kamal Pohar, MD

Surgical practice is driven by technology. In this short video segment, Dr. Pohar discusses the importance of using a technology that can deliver a better view of bladder cancer tumors, thus creating greater opportunity to conduct a more complete TURBT.

New Technologies Assist in
Completeness of TURBT

Kamal Pohar, MD

Information is important in information any type of patient care. Dr. Pohar discusses technological advances to aid in more complete TURBTs and improved post-TURBT follow-up.

Blue Light Cystoscopy with Cysview® in the Surveillance of Bladder Cancer: An Interview with Dr. Siamek Daneshmand

Dr. Sia Daneshmand joins Dr, Ashish Kamat in a conversation about the phase III trial that compared flexible Blue Light Cystoscopy with Cysview with flexible White Light Cystoscopy for the detection of bladder cancer during surveillance. This study showed that Blue Light Cystoscopy with Cysview offers significant improvement in the detection of recurrent bladder cancer and the detection of carcinoma in situ, over White Light Cystoscopy alone.

Blue Light Cystoscopy for Diagnosis of Bladder Cancer
– A Journal Club Review by Badrinath Konety

Badrinath Konety, MD, MBA presents key finding from Blue Light Cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multi-center registry published in Urologic Oncology: Seminars and Original Investigations, August 2018. This study evaluated the detection of malignant lesions in patients and documented the change in risk category due to upstaging or upgrading. The authors concluded that Blue Light Cystoscopy with Cysview significantly increases detection rates of CIS and papillary lesions compared to White Light Cystoscopy alone and can result in upstaging or upgrading in about 14% of patients. They also confirmed that repeat use of Cysview is safe.

Blue Light Cystoscopy:
What Urologists Want to Know

Anne Schuckman, MD

Anne Schuckman, MD, presents the information that supports her decision to use Blue Light Cystoscopy with Cysview in the clinic setting. She takes viewers through the study data and her personal experiences.

Everything You Wanted to Know About Blue Light Cystoscopy with Cysview for Surveillance But Were Afraid to Ask

Sia Daneshmand, MD

Dr. Sia Daneshmand discusses use of Blue Light Cystoscopy (BLC) with Cysview in the office/clinic as part of the disease management process. This state-of-the-art procedure started in the operating room using a rigid cystoscope and is now expanding into the office/clinic setting with the approval of Cysvew use with a flexible cystoscope. Dr. Daneshmand focuses on the flex story but also answers questions about his rigid experience as well.

Blue Light Cystoscopy with Cysview for NMIBC: Case Studies and How It Can Change Disease Management

Sima Porten, MD

Dr. Sima Porten discusses her experience using Cysview with both flex and rigid cystoscopes in the clinic and OR, respectively. She shares some of her case experiences and discusses how the use of Blue Light Cystoscopy with Cysview has made a difference in the categorization and management of non-muscle invasive bladder cancer. Not only is this state-of-the-art technology helping her current patients, she explains how it is also shaping the care of new patients as well.